Protein abundancy and mRNA levels of the adipocyte-type fatty acid binding protein correlate in non-invasive and invasive bladder transitional cell carcinomas

International Journal of Oncology

Volumn 13, Issue 2, 1998, Pages 379-383

  Gromova, Irina ^a   Gromov, Pavel ^a   Wolf, Hans ^b   Celis, Julio E ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

A FABP protein and mRNA levels; Progression; Protein profiling; Proteome

Indexed keywords

FATTY ACID BINDING PROTEIN; MESSENGER RNA;

ADIPOCYTE; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION FUNCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA;

EID: 0031847288     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.2.379     Document Type: Article

References (25)

1. Friedell GH, Nagy GK and Cohen SM: The pathology of human bladder cancer and related lesions. In: The Pathology of Bladder Cancer. I. Bryan GT and Cohen SM (eds). CRC Press Inc., Roca Baton FL, pp 11-42, 1983.
2. Pauli BU, Alroy J and Weinstein RS: The ultrastructure and pathology of urinary bladder cancer. In: The Pathology of Bladder Cancer. II. Bryan GT and Cohen SM (eds). CRC Press Inc., Roca Baton FL, pp41-140, 1983.
3. Celis JE, Ostergaard M, Basse B, Celis A, Lauridsen JB, Ratz GP, Andersen I, Hein B, Wolf H, Ørntoft TF and Rasmussen HH: Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res 56: 4782-4790, 1996.
4. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD and Hawkins IR: Superficial bladder cancer: progression and recurrence. J Urol 130: 1083-1086, 1983.
5. Simoneau AR and Jones PA: Bladder cancer: the molecular progression to invasive disease (Review). World J Urol 12: 89-95, 1994.
6. Spruck CH, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsaim YC, Lerner SP, Schmutte C, Yang AS and Cote R: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54: 784-788, 1994.
7. Rosin MP, Cairns P, Epstein JI, Schoenberg MP and Sidransky D: Partial allelotype of carcinoma in situ of the human bladder. Cancer Res 55: 5213-5216, 1995.
8. Birchmcier W and Birchmeier C: Epithelial-mesenchymal transitions in development and tumour progression. In: Epithelial-Mesenchymal Interactions in Cancer. Goldberg ID and Rosen EM (eds). Birkhäuser, Basel, pp1-15, 1995.
9. Sidransky D, von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P, et al: Identification of p53 gene mutations in bladder cancers and urine samples. Science 252: 706-709, 1991.
10. Lopez-Beltran A, Croghan GA, Croghan I, Huben RP, Mettlin C and Gaeta JF: Prognostic factors in survival of bladder cancer. Cancer 70: 799-807, 1992.
11. Kern WH: The grade and pathologic stage of bladder cancer. Cancer 53: 1185-1189, 1984.
12. Jordan AM, Weingarten J and Murphy WM: Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading? Cancer 60: 2766-2774, 1987.
13. Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF and Williams KL: Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev 13: 19-50, 1996.
14. Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Ørntoft TF, Wolf H and Celis JE: Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res 57: 4111-4117, 1997.
15. Anderson L and Seilhamer J: A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18: 533-537, 1997.
16. Celis JE, Ratz G, Basse B, Lauridsen JB and Celis A: High resolution two-dimentional gel electrophoresis of proteins: isoelectric focusing and non-equilibrium pH gradient electrophoresis (NEPHGE). In: Cell Biology: A Laboratory Handbook. III. Celis JE (ed). Academic Press, pp222-230, 1994.
17. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
18. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE and Spiegelman BM: Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377-1379, 1996.
19. Madsen P, Rasmussen HH, Leffers H, Honore B and Celis JE: Molecular cloning and expression of a novel keratinocyte protein psoriasis-associated fatty acid-binding protein (PA-FABP) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J Invest Dermatol 99: 299-305, 1992.
20. Veerkamp JH, Paulussen RJ, Peeters RA, Maatman RG, van Moerkerk HT and van Kuppevelt TH: Detection, tissue distribution and (sub)cellular localization of fatty acid-binding protein types. Mol Cell Biochem 98: 11-18, 1990.
21. Glatz JF, York MM, Cistola DP and van der Vusse GJ: Cytoplasmic fatty acid binding protein: significance for intracellular transport of fatty acids and putative role on signal transduction pathways. Prostaglandins Leukot Essent Fatty Acids 48: 33-41, 1993.
22. Spitsberg VL, Matitashvili E and Gorewit RC: Association and coexpression of fatty-acid-binding protein and glycoprotein CD36 in the bovine mammary gland. Eur J Biochem 230: 872-878, 1995.
23. Yang Y, Spitzer E, Kenney N, Zschiesche W, Li M, Kromminga A, Muller T, Spener F, Lezius A, Veerkamp JH, et al: Members of the fatty acid binding protein family are differentiation factors for the mammary gland. J Cell Biol 127: 1097-1109, 1994.
24. Glatz JF, Borchers T, Spener F and van der Vusse GJ: Fatty acids in cell signalling: modulation by lipid binding proteins. Prostaglandins Leukot Essent Fatty Acids 52: 121-127, 1995.
25. Hunt CR, Ro JH, Dobson DE, Min HY and Spiegelman BM: Adipocyte P2 gene: developmental expression and homology of 5′-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci USA 83: 3786-3790, 1986.